Expiring federal contract
36C25226P0101 — Petnet Solutions, INC.
Department of Veterans Affairs
- Contract / PIID
- 36C25226P0101
- Incumbent
- Petnet Solutions, INC.
- Incumbent UEI
- Z63RLN31BEE5
- Current end date
- November 30, 2026
- Potential total value
- $110,000
- Obligated
- $110,000
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Not stated
- Start date
- December 1, 2025
- Place of performance
- TN
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
PET RADIOPHARMACEUTICALS
Likely rebid window (estimate)
- Sources Sought / RFI: about Nov 2025 – May 2026 (6–12 months before the end date)
- RFP: about Jul 2026 – Sep 2026 (2–4 months before the end date)
In the final months before the current end date.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Veterans Affairs (NAICS 325412)
- 36C25927F0028 — Janssen Biotech INC · ends November 20, 2026 · $385K
- 36C24126F0039 — Medi-physics, INC. · ends November 21, 2026 · $100K
- 36C25026N0181 — Schaaf Drugs, LLC · ends November 22, 2026 · $681K
- 36C24626N0323 — Cardinal Health 414, LLC · ends November 30, 2026 · $323K
- 36C26023P0532 — Cardinal Health 414, LLC · ends November 30, 2026 · $337K
- 36C26224P0297 — Rls (USA) INC. · ends November 30, 2026 · $1.1M
- 36C26226N0112 — Novartis Pharmaceuticals Corporation · ends November 30, 2026 · $4.3M
- 36C26227N0156 — Novartis Pharmaceuticals Corporation · ends November 30, 2026 · $769K
- 36C24726F0053 — Exelan Pharmaceuticals INC · ends December 7, 2026 · $4.8M
- 36C24126P0074 — Trillamed LLC · ends December 10, 2026 · $927K